5Kanat A. Risk factors for neurosurgical site infections after craniotomy: a prospective muhicenter study of 2944 patients. Neurosurgery, 1998,43 : 189-190.
6Klibanov OM,Filicko JE,DeSimone JA Jr,et al. Sensorineural hearing loss associated with intrathecal vancomycin. Ann Pharmacother, 2003,37 : 61-65.
7Smith RL, Evans HL, Chong TW, et al. Reduction in rates of methicillin-resistant Staphylococcus aureus infection after introduction of quarterly linezolid-vancomycin cycling in a surgical intensive care unit. Surg Infect (Larchmt), 2008,9 : 423 -431.
8Jones RN, Kohno S, Ono Y, et al. ZAAPS International Surveillance Program (2007) for linezolid resistance:results from 5591 Gram-positive clinical isolates in 23 countries. Diagn Microbiol Infect Dis, 2009,64 : 191-201.
9Beer R, Engelhardt KW, Pfausler B, et al. Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains. Antimicrob Agents Chemother, 2007,51 : 379-382.
10Myrianthefs P, Markantonis SL, Vlachos K, et al. Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients. Antimicrob Agents Chemother, 2006,50: 3971-3976.
